New Animal Drugs For Use In Animal Feeds; Monensin and Bacitracin Methylene Disalicylate

摘要

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Elanco Animal Health, A Division of Eli Lilly & Co. The supplemental NADA provides for using approved single ingredient monensin and bacitracin methylene disalicylate (BMD) Type A medicated articles to make an additional approved combination for a monensin/BMD Type C medicated turkey feed.